Novel genotypes in Helicobacter pylori involving domain V of the 23S rRNA gene.

作者: Leonardo Garrido , Hector Toledo

DOI: 10.1111/J.1523-5378.2007.00506.X

关键词:

摘要: Background: Helicobacter pylori is a pathogenic bacterium that infects half of the human population. In Chile, between 55% and 79% people are colonized by H. . At present, therapeutic strategies to eradicate depend on knowledge its resistance antibiotics. The clarithromycin in associated with point mutations 23S rRNA. This study analyzes rRNA gene minimum inhibitory concentration (MIC) for isolates from patients metropolitan region Chile. Materials methods: 50 dyspeptic no history exposure were tested agar dilution method. Resistant strains analyzed polymerase chain reaction-based restriction fragment length polymorphism sequencing. Results: Primary was observed 10 (20%). A single mutation detected four two or more other six cases. C2147G transversion G1939A, T1942C, A2142G transitions peptidyltransferase domain V novel. Conclusions: shows: 1, novel variants gene; 2, high prevalence displaying primary low level MIC an urban area Metropolitan Region

参考文章(23)
A Occhialini, M Urdaci, F Doucet-Populaire, C M Bébéar, H Lamouliatte, F Mégraud, Macrolide resistance in Helicobacter pylori: rapid detection of point mutations and assays of macrolide binding to ribosomes. Antimicrobial Agents and Chemotherapy. ,vol. 41, pp. 2724- 2728 ,(1997) , 10.1128/AAC.41.12.2724
Erika Bruck, National Committee for Clinical Laboratory Standards. Pediatrics. ,vol. 65, pp. 187- 188 ,(1980)
F Megraud, F Bonnet, M Garnier, H Lamouliatte, Characterization of "Campylobacter pyloridis" by culture, enzymatic profile, and protein content. Journal of Clinical Microbiology. ,vol. 22, pp. 1007- 1010 ,(1985) , 10.1128/JCM.22.6.1007-1010.1985
J Versalovic, D Shortridge, K Kibler, M V Griffy, J Beyer, R K Flamm, S K Tanaka, D Y Graham, M F Go, Mutations in 23S rRNA are associated with clarithromycin resistance in Helicobacter pylori. Antimicrobial Agents and Chemotherapy. ,vol. 40, pp. 477- 480 ,(1996) , 10.1128/AAC.40.2.477
Michael G. Bruce, Dana L. Bruden, Brian J. McMahon, Thomas W. Hennessy, Alisa Reasonover, Julie Morris, Debby A. Hurlburt, Helen Peters, Frank Sacco, Patrick Martinez, Michael Swenson, Douglas E. Berg, Debra Parks, Alan J. Parkinson, Alaska sentinel surveillance for antimicrobial resistance in Helicobacter pylori isolates from Alaska native persons, 1999-2003. Helicobacter. ,vol. 11, pp. 581- 588 ,(2006) , 10.1111/J.1523-5378.2006.00462.X
R C Goldman, D Zakula, R Flamm, J Beyer, J Capobianco, Tight binding of clarithromycin, its 14-(R)-hydroxy metabolite, and erythromycin to Helicobacter pylori ribosomes. Antimicrobial Agents and Chemotherapy. ,vol. 38, pp. 1496- 1500 ,(1994) , 10.1128/AAC.38.7.1496
James S. Hoffman, David R. Cave, Treatment of Helicobacter pylori. Current Opinion in Gastroenterology. ,vol. 17, pp. 30- 34 ,(2001) , 10.1097/00001574-200101000-00006
Gregory G. Stone, Dee Shortridge, Robert K. Flamm, James Versalovic, Jill Beyer, Ken Idler, Laura Zulawinski, S. Ken Tanaka, Identification of a 23S rRNA Gene Mutation in Clarithromycin‐Resistant Helicobacter pylori Helicobacter. ,vol. 1, pp. 227- 228 ,(1996) , 10.1111/J.1523-5378.1996.TB00043.X